Patent Assignment
Reel/Frame 059213/0272
Assignment of Assignor's Interest
Recorded: 2022-03-09
Pages: 8
Assignee
BIOTIME, INC.
1010 ATLANTIC AVENUE, #102, ALAMEDA, CALIFORNIA, 94501
Covered Properties
(3)
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/542,992 →
Publication:
US 2022/0160833
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/542,997 →
Publication:
US 2022/0088137
Methods for Detecting and Modulating the Embryonic-Fetal Transition in Mammalian Species
Application:
17/543,020 →
Publication:
US 2022/0088138
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 9, 2022
From: LINEAGE CELL THERAPEUTICS, INC.
To: AGEX THERAPEUTICS, INC.
Reel/Frame 059213/0084 →
Change of Name
Mar 9, 2022
From: BIOTIME, INC.
To: LINEAGE CELL THERAPEUTICS, INC.
Reel/Frame 059357/0105 →
Assignment of Assignor's Interest
Mar 11, 2022
From: AGEX THERAPEUTICS, INC.
To: REVERSE BIOENGINEERING, INC.
Reel/Frame 059242/0007 →
Security Interest
Nov 10, 2023
From: AGEX THERAPEUTICS, INC.; RECYTE THERAPEUTICS, INC.; REVERSE BIOENGINEERING, INC.
To: JUVENESCENCE LIMITED
Reel/Frame 065529/0594 →